AOD-9604 dosage chart
This summary table compares available dose amounts and schedules by administration route.
| Route | Dose | Frequency & duration |
|---|---|---|
| Oral | ~1 mg | Daily · ~24 wk |
| Injectable | 250–500 mcg | 1–2x daily · 8–12 wk |
AOD-9604 dosage by administration route
AOD-9604 oral dosage
Reported-use amounts for AOD-9604 are ~1 mg per administration, daily, for approximately 24 wk.[8]
AOD-9604 is a modified growth-hormone fragment associated with fat-metabolism signaling. It is a different molecule from the native HGH fragment 176–191 and does not provide full growth-hormone replacement.[7][1][2][8]
AOD-9604 injectable dosage
Reported-use amounts for AOD-9604 are 250–500 mcg per administration, 1–2x daily, for 8–12 wk. One reported once-daily subcutaneous progression uses 250 mcg during weeks 1–4, followed by 500 mcg during weeks 5–12. This describes an 8–12-week course without the twice-daily frequency of some other reported patterns.[8][9]
AOD-9604 is a modified growth-hormone fragment associated with fat-metabolism signaling. It is a different molecule from the native HGH fragment 176–191 and does not provide full growth-hormone replacement.[3][4][1][2][8]
Frequency and timing
Morning is the listed timing for oral use. Injections are commonly timed in the morning or before a workout.[5][6][7][8]
Cycle length and breaks
Oral: ~24 wk. Injectable: 8–12 wk. A standard break interval between courses is not established.[8]
AOD-9604 dosage calculator
Convert your chosen AOD-9604 amount into volume and U-100 syringe units. Adjust the inputs to match your vial and preparation.
AOD-9604 safety and side effects
Side effects and long-term safety
Human long-term safety, dose-response and route-specific risks remain unresolved. Clinical usefulness is limited; product purity and FDA compounding concerns require separate attention.[3][4]
Route-specific dosing limits
The main cautions are FDA compounding safety concerns, unapproved-product quality, sports prohibition, and missing safety support for special populations. Reported-use oral and injectable schedules and additional protocol patterns are not established human treatment regimens or approved product instructions.[3][4][9][8]
Common AOD-9604 dosage questions
Can AOD-9604 doses be transferred between routes?
What dosage is listed for AOD-9604?
Reported-use amounts for AOD-9604 are ~1 mg per administration, daily, for approximately 24 wk.[8]
Does AOD-9604 have a standard cycle or break interval?
Oral: ~24 wk. Injectable: 8–12 wk. A standard break interval between courses is not established.[8]
Sources
Show citationsHide citations
- [1]Effects of oral administration of a synthetic fragment of human growth hormone on lipid metabolismAmerican Journal of Physiology-Endocrinology and Metabolism. animal.
- [2]Metabolic studies of a synthetic lipolytic domain of human growth hormone in obese Zucker ratsEndocrinology / metabolic research. animal.
- [3]Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety RisksU.S. Food and Drug Administration, 2026-04-22. regulatory.
- [4]Search Drugs@FDA for AOD-9604openFDA / U.S. Food and Drug Administration. database query.
- [5]AOD-9604 MetabolicDrugs in R&D. review.
- [6]Obesity pharmacotherapy: current perspectives and future directionsCurrent Obesity Reports / PMC. review.
- [7]Safety and Tolerability of the Hexadecapeptide AOD9604 in HumansJournal of Endocrinology and Metabolism, 2013-04. human clinical.
- [8]PepFlow peptide cheat sheet — reported-use and product-orientation reference (not clinical research)PepFlow. reference catalog.
- [9]AOD-9604 — Everything Peptide reported protocol (educational reference, not clinical evidence)Everything Peptide. reference catalog.


